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Spatially-resolved profiling of carbon nanotube uptake across cell 
lines 
H. D. Summers,a P. Rees,a J. T-W. Wang,b K. T. Al-Jamalb 
 
 
The internalisation and intra-cellular distribution of carbon nanotubes (CNT) has been quanitatively 
assessed using imaging flow cytometry. Spatial analysis of the bright field images indicates the 
presence of a small sub-population (5% of cells) in which the internalised CNTs are packed into 
pronounced clusters, visible as dark spots due to strong optical scattering by the nanotubes. The 
area of these spots can be used as a label-free metric of CNT dose and we assess the relative uptake 
of charge-neutral CNTs, over a 24 hour exposure period across four cell types: J774 mouse 
macrophage cells,  A549 and Calu-6 human lung cancer cells, MCF-7 human breast cells. The relative 
dose as indicated by the spot-area metric, closely correlates to results using the same CNT 
preparation, conjugated to a FITC-label and shows pronounced uptake by the J774 cells leading to 
a mean dose that is > 60% higher than for the other cell types. Spatial evaluation of dosing clusters 
is also used to quantify differences in uptake by J774 cells of CNTs with different surface 
functionalisation. While the percentage of CNT-cluster positive cells increases from 5% to 19% when 
switching from charge-neutral CNTs to poly-cationic, dendron functionalised CNTs, the single cell 
level analysis of internalised clusters indicates a lower dose per cell of poly-cationic CNTs relative 
to the charge-neutral CNTs. We concluded that there is dose homeostasis i.e., the population-
averaged cellular dose of CNTs remained unchanged. 
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Introduction 
Research into the use of carbon nanotubes (CNTs) as drug/gene 
delivery vehicles is a rapidly increasing area of activity in the 
biomedicine field1,2. Because of their readily available surface 
and hollow interior, CNTs can carry high therapeutic payloads 
when altered by various chemical modifications3–5. An 
additional advantage is that their cellular internalisation can 
follow diverse pathways6,7. Both active endocytosis and passive 
diffusion (needle-like cell membrane penetration) have been 
described. To understand the cellular trafficking routes, 
distribution patterns and the biological fates of CNTs, there 
have been studies employing methods for intra-cellular 
detection and further quantification of CNTs. Labelling CNTs 
with either fluorophores or radio-isotopes are the most 
commonly used strategies for visualisation and/or 
quantification8,9. These methods provide superb resolution or 
sensitivity, respectively, but the measurements rely on the 
signals from the probes and the stability of these tags when 
used with CNTs should be taken into consideration. Raman 
spectroscopy and multi-photon luminescence microscopy have 
been developed to image CNTs utilising their intrinsic optical 
properties rather than by indirect detection10–12. Transmission 
electron microscopy is also a useful tool to characterise the 
tubular structure of CNTs with very high spatial resolution, but 
the involvement of laborious procedures and the requirement 
of trained personnel make these unfavourable routine 
techniques.  
 
The most commonly used approach to cellular analysis of large 
numbers of cells, sufficient to provide statistical certainty, is 
flow cytometry. In this regard, label-free flow cytometry-based 
analyses provide an approach to assess the cellular interaction, 
internalisation and localisation of CNTs in a high-throughput 
fashion and label-free manner13–18. In this paper we present 
data using a recent advance in this technology – imaging 
cytometry. This provides images of cells analysed within a flow 
system and so adds the ability to discern spatial patterns of 
reporting agents or natural label-free reporters. Previous work 
in the area by Marangon et. al. demonstrated that the imaging 
cytometer is capable of high throughput imaging at sufficient 
spatial resolution to allow analysis of the intracellular 
translocation of CNTs19. In this case the optical absorption and 
scattering properties of the CNTs were found to be sufficiently 
pronounced to provide label-free analysis, based on bright-field 
or dark-field imaging. Other researchers have reported on the 
use of imaging cytometry for analysis of fluorescent20 and 
metallic21 nanoparticles, based on optical emission or scattering 
properties.  
 
In this paper, we follow a similar experimental approach and 
analyse CNT-cell interactions from image-based metrics, 
acquired from all individual cells within large sample 
populations, using an imaging flow cytometer. We present a 
quantitative assessment of the relative dose and its spatial 
distribution within the cell and make direct comparisons of the 
nanoparticle pharmacology for multiple cell types and differing 
particle chemistry.  We also concentrate on the development of 
label-free quantification. Comparative assessment of the 
uptake of differing nanoparticle types into multiple cell lines is 
extremely challenging when using fluorescence or light scatter, 
quantified at the whole cell level, as a reporting metric. This is 
the most commonly used approach for flow cytometry22,23 but 
it requires accurate calibration of the nanoparticle optical signal 
from different samples, especially when the particle physio-
chemical characteristics are being varied. The added 
discriminative power stemming from spatial resolution, offered 
by our method here, allows dose quantification based on area 
rather than intensity metrics24,25, making the measurement 
robust in response to fluctuation in the reporting signal level. It 
also allows us to profile the internalisation dynamics of the 
CNTs. This provides information on the relative importance of 
the biological mechanisms that drive nanoparticle 
internalisation and the intra-cellular form of the resultant 
particle dose.  
Experimental 
Materials  
Human lung cancer cells A549 (ATCC® CCL-185™), human lung 
cancer cells Calu-6 (ATCC® HTB-56™), human breast cells MCF-
7 (ATCC® HTB-22™), and mouse macrophage cells J774 (ATCC® 
TIB-67™) are purchased from ATCC (USA). Minimum Essential 
Medium, Dulbecco's Modified Eagle Medium (DMEM), 
Advanced RPMI-1640 medium, penicillin/streptomycin, 
trypsin/EDTA, and phosphate buffered saline (PBS) were 
obtained from Gibco (Thermo Fisher Scientific Inc., UK). Fetal 
bovine serum (FBS) was purchased from First Link Ltd. (UK). BD 
CellFIXTM (10x concentrated) was purchased from BD 
Biosciences (UK). 
 
Methods of cell culture and treatments 
Synthesis of CNTs: The synthesis of poly-cationic dendron 
functionalised CNT (CNT(++)) has been reported previously4,26. 
The amine-functionalised CNT-FITC conjugate (CNT(+)) and its 
derivative with further IgG conjugation CNT(n), were 
synthesised following the protocols that have also been 
reported previously26. 
   
Cell culture: A549 cells were cultured in DMEM, MCF-7 cells 
were cultured in MEM, and Calu-6 and J774 cells were cultured 
in Advanced RPMI-1640 medium, all at 37°C in 5% CO2.  Culture 
media was supplemented with 10% FBS, 100 U/ml penicillin, 
100 µg/ml streptomycin and 1% L-glutamine (Sigma). Cells were 
routinely grown in 75 cm2 tissue culture flasks and passaged 
twice a week, after detachment with Trypsin/EDTA, when 
reaching 80% confluency. 
 
For uptake studies, cells were seeded in 24-well plates 
(triplicates) and incubated with CNT(n), CNT(+) or CNT(++) at a 
concentration of 10 µg/ml for 24 h. Cells were then washed with 
PBS, trypsinised and collected in culture media. Collected cells 
were washed three times with PBS by centrifugation (200 g, 5 
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min) and fixed using diluted BD CellFIX (1:10) at room 
temperature for 15 min. Cells were centrifuged again and re-
suspended in PBS. Cells were kept at 4 °C in the dark until flow 
cytometric analysis. Previous work4 using two different 
cytotoxic assays confirmed that the dendron-functionalised 
CNTs were nontoxic to cells following 24 hours of exposure, up 
to concentrations of 80 g/ml. 
 
Flow cytometry 
Cell images were acquired with an Imagestream 100 flow 
cytometer (Merck Millipore, Seattle, WA); bright field, dark field 
and fluorescence images were collected for each cell within 
sample sets of at least 10,000 cells. A 488 nm wavelength 
excitation laser, at a power of 100 mW was used for excitation 
of the FITC fluorophore. Untreated cells were imaged as 
controls. All image analysis was done within the Ideas software 
environment (Merck Millipore, Seattle, WA).  
Results and discussion 
CNT uptake at the population level 
The quantification of content of a neutrally-charged CNT type 
(CNT(n))27,  based on image analysis in three channels: bright 
field (BF, optical transmission), dark field (DF, optical scatter at 
900) and fluorescence was performed. Examples of the three 
image sets for six typical, J774 cells are shown in Figure 1. 
 
The high optical scattering coefficient of the CNTs leads to 
clearly visible, dark spots in the bright field images and 
corresponding bright pixels in the dark field channel. The FITC 
signal appears as a diffuse patterning across the whole cell with 
additional high intensity areas, correlating to the CNT clusters, 
seen in the bright and dark field images. This is in agreement 
with our previous studies which showed that CNTs can enter 
cells through different pathways, with observation of individual 
nanotubes or CNT clusters in vesicular compartments inside 
cells6,29. The FITC signal is present in the majority of cells (96% 
of population), confirming that regardless of whether in diffuse 
or clustered form the internalisation of the nanotubes is 
widespread. 
 
To assess the validity of quantifying CNT uptake using a label-
free method, we compare the mean intensity per cell in the DF, 
FITC and BF channels for the 4 cell types. The results for a 24 
hour exposure to CNT(n), are shown in Figure 2. They are based 
on the use of population averaged parameters and so report on 
the mean CNT load within each cell culture. The mean value of 
pixel intensity is used for the DF and FITC channels; to 
parameterise the BF image we use an area metric. The marked 
image contrast produced in the bright field channel by the CNT 
clusters allows masking of the dark spots using a simple 
thresholding of an inverted image. From this a dark spot area 
metric is obtained (Figure 2, grey bars). This is a more robust 
measure than the mean channel signal per cell as it is 
independent of signal intensity (as long as intensity is above the 
mask threshold).  
 
 
 
In Figure 2a, a comparison is made of the signal intensity from 
CNT exposed cells (coloured bars) to that from a CNT-free 
control sample (black line). The signal from exposed cells is 
statistically different to the control in all data sets bar one (95% 
confidence level, all except DF signal in Calu6 cells). So the 
presence of the nanoparticles is reported by all three signal 
modalities. However, they are not all robust enough to quantify 
and compare the nanoparticle dose between cell types. The 
level of the reporting signal subtracted from the background 
(signal-background) is shown in Figure 2b. The results from the 
FITC labelled cells show that the CNT loading is greatest in the 
J774 cell line which is unsurprising given the phagocytic nature 
of this cell type. The uptake into A549 cells is ~ 40% lower whilst 
the MCF7 and Calu6 cells show no significant difference with 
both cell types having ~ 30% of the J774 CNT content. In the DF 
channel the high background scatter produced by the cells leads 
to a low signal to background ratio, especially for the MCF7 and 
Calu6 cells in which the control sample scatter is of an 
equivalent level to that produced by the CNTs (Figure 2a, black 
lines). Thus the DF channel cannot provide a meaningful, 
 
Figure 1: a.-f. Panel of typical images from the Imagestream 
Cytometer for J774 cells. Each cell is simultaneously imaged 
in a dark field, a fluorescent and a bright field channel. 
Incubation conditions: (CNT(n)), 24 h, 10 µg/ml. 
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statistically robust metric. The dark spot area metric from the 
BF channel does correlate reasonably well to the FITC signal (a 
quantitative label), indicating the same relative scaling of CNT 
levels between cell types. However, this data is also subject to 
large uncertainty bounds for the Calu6 cell line, where the 
increase in signal from the CNTs is smaller than the background 
value obtained from control samples. 
 
  
Figure 2: a. Relative signal from mean DF intensity per cell 
(yellow bars), mean fluorescence per cell (green bars) and area 
of dark spots in the BF image (grey bars). All measures are 
normalised to the J774 cell line value. The black lines indicate 
the relative size of the background signal (obtained from CNT-
free cells). The error bars represent the s.e.m. (N > 2000 for all 
data). b. signal-background measure (background taken to be 
the value from control, CNT-free cell samples), normalised to the 
signal from the control sample for the J774 cell line. The black 
lines indicate the size of the background signal. Incubation 
conditions: (CNT(n)), 24 h, 10 µg/ml.  
 
The image masking of dark spots allows quantification of the 
spatial location of CNTs as the proportion of the FITC signal 
within these ‘dark-spot’ areas can be compared to that from the 
whole cell. Whilst there is a higher signal density corresponding 
to the CNT clusters this does not constitute a large fraction of 
the total: In the J774 cell line the dark CNT clusters account for 
4% of cell area and contain 7% of the total FITC signal. The 
majority of the CNT dose is therefore in a diffuse form. 
 
 
CNT uptake at the single cell level 
Having established that population-averaged metrics do 
indicate the presence of CNTs within cells, we proceed to 
analyse the cell-to-cell variation of these image derived 
parameters. We begin with a study of the correlation between 
DF and BF derived parameters in cells exposed to CNT(n) for 24 
hours. These metrics have been used previously by Marangon 
et. al. to quantify CNT uptake in endothelial cells19. Scatter plots 
of DF intensity versus integrated BF intensity (mean per cell), for 
the four cell types are shown in Figure 3. The results indicate 
the presence of two distinct sub-populations: A majority group 
sits at the right hand side of the plots, close to the control 
population mean (black crosses in Figure 3). This group has a 
relatively high BF intensity and shows minimal correlation 
between BF and DF parameter values (r < 0.05). A minority 
group sits to the left of the plot, differentiated by a low BF 
channel intensity (log10 BF intensity < 0) and a clear anti-
correlation between the BF and DF intensity values (r-range of  
-0.45 to -0.67). Inspection of the cell images for this minority 
sub-group, which constitutes ~ 5% of the total cell population, 
indicates the presence of pronounced dark spots in the BF 
image, corresponding to dense intra-cellular clusters of CNTs 
(see Electronic Supplementary Information, S1). These CNT 
clusters reduce the BF mean intensity to a value less than the 
image background and boost the DF signal due to their high 
optical scattering coefficient. We therefore label this group of 
cells as ‘CNT-cluster positive’ (encompassed by dashed red circle 
in Figure 3). It should be noted that this is a classification of the 
sub-population which has internally agglomerated CNTs rather 
than that which has CNTs per se. The majority population on the 
right hand side of the plots in Figure 3 may have internalised 
CNTs in a diffuse form that does not significantly alter the 
optical transmission or scattering characteristics of these cells.   
 
Our results for the CNT-cluster positive cells are similar to 
previous reports by Marangon et. al. using imaging cytometry19, 
which also demonstrated a clear anti-correlation between dark 
and bright field signals (r = -0.68). However, in these 
experiments > 80% of the cells were identified as being CNT 
positive, whereas in our work this number is only 5%.  We 
attribute this variance to the different cell lines and CNT type 
used. Similar results to those reported by Marangon et. al. were 
obtained from an extended exposure over 72 hours using a 
poly-cationic dendron-functionalised CNTs4 (CNT(++)) (see 
Electronic Supplementary Information, S2).  
  
a. 
b. 
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Figure 3: Scatter plots of dark field versus bright field intensity for the four cell lines (N > 2,000 in all cases). The black crosses 
indicate the positions of the mean values for the control samples not exposed to CNTs. The CNT-cluster positive cells (log10 BF < 0) 
are indicated by the red dashed circle. Incubation conditions: (CNT(n)), 24 h, 10 µg/ml.  
 
 
 
Having identified the CNT-cluster positive sub-fraction of cells 
we can more accurately assess the relative loading profile of the 
four cell lines. The identification of a relatively small fraction of 
CNT cluster positive cells means that access to spatial 
information within the cell images is essential for accurate 
assessment of the CNT content. Whilst the population mean of 
the signal intensities (Figure 2) shows clear differences between 
cell types, this will not be representative of the true CNT 
content when only a small fraction of the cells contributes to 
the population mean. For example, the mean dark spot area 
reported in Figure 2 stems from a signal in ~ 100 cells averaged 
over all 2000+ cells. 
 
The mean FITC fluorescence and BF dark spot area for the CNT-
cluster positive group, is shown in Figure 4 (signal - 
background). The use of only CNT-cluster positive cells for 
analysis now provides a BF channel, dark spot area metric that 
is significantly greater than the control samples, for all cell 
types. Thus this, label-free metric can be used as a robust and 
quantitative indicator of the relative CNT content across the cell 
lines. 
 
Determination of CNT(n) aggregate size in cells 
The differences in CNT uptake shown in Figure 4 are an average 
over the CNT-cluster positive sub-group of cells. To profile the 
contribution of individual cells to this mean difference we 
calculate the cumulative distribution function (CDF) for the BF 
dark spot area metric: % of cells with a given sum total of dark 
areas in BF image. This is presented in Figure 5 and provides a 
profile of the spatial localisation of CNTs within the cell. The 
insert images are positioned on the x-axis to show typical cells 
for the particular spot area range. The data and images show 
that the increased loading into J774 cells (and to a lesser extent 
into A549 cells) is associated with larger intra-cellular clusters 
rather than increased numbers of clusters per cell.  
 
 
Figure 4: CNT-cluster positive, population: values for mean 
fluorescence per cell (green bars) and BF dark spot area (grey 
bars). Data represents signal – background relative to the J774 cell 
value. The black lines indicate the size of the background signal 
(from control samples). Errors bars show s.e.m. (N>140) 
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Figure 5: Cumulative distribution frequency (% of cells) of dark 
spot area for J774 (red line), A549 (green line), MCF7 (blue line) 
and Calu6 (magenta line) cells. The image inserts display cells 
(J774) typical for the particular range of dark spot area.   
 
To further investigate why the J774 cell line shows a different 
behaviour to the other cell lines we referred to the nanotube 
colloidal dispersion profiles (see Electronic Supplementary 
Information, Table S1). The DLS measurements report indicated 
agglomeration of CNT(n) suspensions with poor size quality 
report indicating the polydisperse nature of the sample (data 
not shown). The presence of elevated numbers of large intra-
cellular CNT clusters in the J774 cells is thus explained by the 
increased capacity of these phagocytic cells to internalise the 
CNT(n) agglomerates.  
 
 
Profiling the effect of CNT surface properties 
Using the J774 cell line we compared cellular CNT content 
following 24 hours exposure to the charge neutral (CNT(n)), 
amine functionalised27 (CNT(+)) and poly-cationic dendron-
functionalised CNTs4 (CNT(++)). The results are shown in Figure 
6 in the form of scatter plots of DF intensity versus BF intensity. 
Again, there are 2 distinct populations within each plot with a 
small, low BF intensity, CNT-positive group identified as having 
pronounced intra-cellular CNT clusters (left hand side of plots). 
The percentage of CNT-cluster positive cells increased with CNT 
surface charge: CNT(n) : 5%, CNT(+) : 9%, CNT(++): 19% (Figure 
6: number of cells in left hand sub-group as a % of all cells 
displayed).  
 
Thus exposure to poly-cationic CNTs produced the highest % 
population as previously reported using conventional side 
scatter analysis by flow cytometry4. The population of cells 
showing clustered internalisation of the CNT(n) is significantly 
smaller (Figure 6a cf. Figure 6b and 6c). Reduced aggregation of 
CNT (++) and CNT(+), driven by increased electrostatic repulsion 
among nanotubes, has been confirmed with transmission 
electron microscopy in our previous study4 (see Electronic 
Supplementary Information, S3). Thus this reduced uptake of 
the CNT(n) is possibly due to their aggregation or their less 
pronounced surface positive charge compared to CNT (+)/(++).  
 
 
Figure 6: Scatter plots of dark field versus bright field intensity 
for the three CNT preparations (N > 2,000 in all cases). The black 
crosses indicate the positions of the mean values for the control 
samples not exposed to CNTs.  Incubation conditions: (CNT(n)), 
24 h, 10 µg/ml. 
 
 
Packing density of CNT of different surface properties in J774 cells 
To further investigate the form of the intra-cellular CNT 
clustering we analysed the relationship between total BF 
intensity per cell and total dark spot area in each BF J774 cell 
image, for the CNT-cluster positive cell population (see Figure 
7), for CNT(n), CNT(+) and CNT(++). The three data sets in Figure 
7 all conform to the same functional form, confirming that the 
relationship between mean image brightness per cell and the 
area of CNT-related dark spots remains the same, regardless of 
the CNT surface properties. This indicates that the ‘packing 
density’ of the intra-cellular clusters, which give rise to the dark 
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spots, is the same for all CNT types (fixed relationship between 
CNT cluster area and optical attenuation). Whilst the functional 
form of the uptake is unchanging for the different derivatives, 
the distribution of cells across this profile is not. In particular, 
there is a marked increase in number of cells with a high dark 
spot area when loaded with the neutral CNT(n) (Figure 7). As 
seen in the data from multiple cell lines (Figure 4), the 
agglomeration of the CNT(n) leads to pronounced clusters 
within the cells which are detected via the BF image analysis. 
 
The absolute change in mean BF intensity per cell relative to the 
control, for the populations with clustered (CNT-cluster 
positive) and diffuse CNTs (CNT-cluster negative) is shown in 
Figure 8. There is a statistically meaningful signal reduction in 
all cases, thus it would appear that the presence of diffuse CNTs 
within the cytoplasm is sufficient to produce a measurable 
change in optical transmission. This data underlines the 
importance of spatial discrimination of the internalised CNT 
dose as the diffuse and clustered uptake group exhibit different 
trends. The agglomeration of the CNT(n) preparation produces 
a pronounced decrease in BF signal in those cells exhibiting 
clustered uptake, whilst the signal in the cell population with 
diffuse uptake is relatively insensitive to the type of CNT. The 
total CNT uptake across the cell population is a function of the 
dose per cell and the number of cells. For the CNT(n) 
preparation, the high CNT content in the population group 
showing internal clusters (~ 2x CNT(++) value) is offset by the 
low numbers of these cells (5% cf. 19%) and so the average CNT 
dose for the whole population is similar for all CNT types 
(indicated by grey bars in Figure 8). 
 
 
Summary and conclusions 
Our results show that quantification and spatial resolution of 
the light signal, transmitted through nanoparticle loaded cells 
allows label free analysis of particle dose. The validity of bright 
field metrics such as mean intensity per cell or area of dark spots 
as quantifiers of CNT dose is verified by comparison to 
fluorescently labelled control particles. Profiling of the CNT dose 
across a panel of four cell lines shows elevated uptake for 
phagocytic J774 cells and highly-endocytic A549 epithelial cells 
in comparison to Calu6 and MCF7 cell lines. 
 
The processes of nanoparticle exposure and cell uptake are 
determined by the coupled interactions between particles, 
environment and cells30, with complex dynamics driven by 
feedback loops31 and time dependent processes32,33. The 
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resulting quantity and form of the internalised particle dose is 
highly dependent upon cell type and particle surface 
characteristics and can vary greatly from cell to cell. 
Nanoparticle uptake is thus poorly described by mean metrics 
of whole cell quantities, averaged across a population34. In the 
specific case of CNTs, their surface charge state influences the 
propensity to agglomerate, which then determines the relative 
weights of endocytic internalisation, producing internal CNT 
clustering, and direct trans-membrane transport leading to a 
diffuse cytoplasmic CNT dose. A complete understanding of this 
nanoparticle dosing (endocytic vs cytosolic), which can be even 
more crucial for nucleic acid delivery, can only be obtained 
through spatially resolved analyses. 
 
Through the use of imaging cytometry we show that the spatial 
distribution of CNTs within cells is driven by particle-cell 
interactions in which particle decoration and cell type play a 
role. As the level of cationic charge on the CNT surface 
increases, it enhances adhesion to the cell membrane and 
reduces the amount of particle agglomeration. The changes in 
particle dispersion influence the relative uptake in different cell 
types with phagocytic cells able to internalise agglomerates of a 
wide size range. The spatial information obtained from imaging 
cytometry provides an understanding of the complex dynamics 
of particle uptake, which at the whole cell level are potentially 
misleading. Standard assessment, using whole cell metrics, 
indicates only small differences in mean dose per cell for CNTs 
of different surface charge and so points to comparable partico-
kinetics. However, with further information from imaging, a 
very different picture emerges; a dynamic environment in 
which dose homeostasis results from the balance of 
countervailing effects: uptake of high density CNT agglomerates 
by few cells when using low surface charge particles or uptake 
of reduced numbers of disperse CNTs by an increasing number 
of cells as surface charge is increased. 
 
The understanding of the dose-response relationship is an 
essential part of nanotherapeutic or nanotoxicological studies. 
The biological response to an agent can be determined in a 
straightforward manner by monitoring binary outcomes, e.g. 
occurrence of cell death or expression of a transfected gene. 
The assessment of nano-agent dose is much more complex and 
hence difficult to quantify. The accurate determination of 
delivered dose on a cell by cell basis is challenging and most 
studies report instead on population mean metrics or just quote 
exposure concentrations. By adopting an image-based analysis 
we can quantify CNT dose per cell using morphological rather 
than intensity-based metrics. This is a major advance as it allows 
for direct comparison of diverse cell types, because cell or 
experiment related variance due to fluorescence labelling or 
yield efficiency are removed. Thus the current single-
agent/single cell type assay, limited in scope and application, 
can evolve into sophisticated in-vitro studies using multiple cell 
types to mimic the complexity of tissue micro-environments35. 
An additional benefit of using an imaging approach to assess 
dose is that it can provide information relating to biological 
mechanism. The packing density and spatial distribution of the 
intra-cellular dose can be assessed. This provides quantification 
of the local concentration of drug cargos inside cells (e.g. 
agglomerates or single CNT), which then gives indication of 
pathways of uptake (e.g. endocytosis or passive diffusion) – 
particularly relevant information when using CNTs8. Many 
nanoparticle based therapeutics target the nucleus to effect 
genetic reprogramming such as gene silencing4, the dose 
assessment protocols presented here provide spatial 
discrimination of the intra-cellular dose and so could provide 
information on the correlation of nuclear localisation of an 
agent to its therapeutic effect. 
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